Skip to main content
Erschienen in: Quality of Life Research 10/2014

01.12.2014

Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease

verfasst von: Ji Young Hong, Sang A. Lee, Song Yee Kim, Kyung Soo Chung, Sung Woo Moon, Eun Young Kim, Ji Ye Jung, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang, Young Ae Kang

Erschienen in: Quality of Life Research | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The impact of pulmonary nontuberculous mycobacterial (pNTM) disease on health-related quality of life (HRQoL) has not received significant attention in the literature. In this study, we compared the HRQoL in patients with pNTM disease and healthy subjects and identified influencing factors using EuroQol 5D (EQ-5D) data.

Methods

The present study used an age- and sex-matched case–control analysis from a cohort of 85 pNTM patients and 340 participants from a national survey. Baseline EQ-5D utility scores and EQ-5D visual analog scale (VAS) scores were measured in both groups. In patients with pNTM disease, the factors affecting EQ-5D were identified using multiple linear regression analysis.

Results

While the median EQ-5D VAS scores were lower in pNTM patients than in the control subjects (pNTM, 70; control, 80; P < 0.001), the median EQ-5D utility scores were similar in two groups (both, 1.000, P = 0.878). Interestingly, the percentage of subjects reporting problems on the anxiety/depression dimension was higher for patients with pNTM disease (18.8 %) compared with the control subjects (11.5 %, P = 0.07). In multivariate analysis, increasing severity of forced expired volume in one second (FEV1) decline was associated with a significant decrease in EQ-5D scores of pNTM patients.

Conclusions

This study suggested the EQ-5D may not be useful instrument in pNTM patients due to ceiling effect of EQ-5D and mild disease activity. Patients with pNTM disease tended to report more reduced health status and more problems with anxiety/depression than the healthy controls. Lung function, measured by FEV1, was independently associated with EQ-5D scores in patients with pNTM disease.
Literatur
1.
Zurück zum Zitat Prevots, D. R., Shaw, P. A., Strickland, D., Jackson, L. A., Raebel, M. A., Blosky, M. A., et al. (2010). Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory and Critical Care Medicine, 182(7), 970–976.PubMedCentralPubMedCrossRef Prevots, D. R., Shaw, P. A., Strickland, D., Jackson, L. A., Raebel, M. A., Blosky, M. A., et al. (2010). Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory and Critical Care Medicine, 182(7), 970–976.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Winthrop, K. L., McNelley, E., Kendall, B., Marshall-Olson, A., Morris, C., Cassidy, M., et al. (2010). Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: An emerging public health disease. American Journal of Respiratory and Critical Care Medicine, 182(7), 977–982.PubMedCrossRef Winthrop, K. L., McNelley, E., Kendall, B., Marshall-Olson, A., Morris, C., Cassidy, M., et al. (2010). Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: An emerging public health disease. American Journal of Respiratory and Critical Care Medicine, 182(7), 977–982.PubMedCrossRef
3.
Zurück zum Zitat Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., et al. (2007). An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine, 175(4), 367–416.PubMedCrossRef Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., et al. (2007). An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine, 175(4), 367–416.PubMedCrossRef
4.
Zurück zum Zitat Huang, J. H., Kao, P. N., Adi, V., & Ruoss, S. J. (1999). Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: Diagnostic and management limitations. Chest, 115(4), 1033–1040.PubMedCrossRef Huang, J. H., Kao, P. N., Adi, V., & Ruoss, S. J. (1999). Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: Diagnostic and management limitations. Chest, 115(4), 1033–1040.PubMedCrossRef
5.
Zurück zum Zitat Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.PubMedCrossRef Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.PubMedCrossRef
6.
Zurück zum Zitat Voll-Aanerud, M., Eagan, T. M., Wentzel-Larsen, T., Gulsvik, A., & Bakke, P. S. (2008). Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine, 102(3), 399–406.PubMedCrossRef Voll-Aanerud, M., Eagan, T. M., Wentzel-Larsen, T., Gulsvik, A., & Bakke, P. S. (2008). Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine, 102(3), 399–406.PubMedCrossRef
7.
Zurück zum Zitat Mehta, M., & Marras, T. K. (2011). Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respiratory Medicine, 105(11), 1718–1725.PubMedCrossRef Mehta, M., & Marras, T. K. (2011). Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respiratory Medicine, 105(11), 1718–1725.PubMedCrossRef
8.
Zurück zum Zitat Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes, 5, 21.PubMedCentralPubMedCrossRef Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes, 5, 21.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.PubMedCrossRef Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.PubMedCrossRef
10.
Zurück zum Zitat Sim, Y. S., Park, H. Y., Jeon, K., Suh, G. Y., Kwon, O. J., & Koh, W. J. (2010). Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease. Yonsei Medical Journal, 51(6), 888–894.PubMedCentralPubMedCrossRef Sim, Y. S., Park, H. Y., Jeon, K., Suh, G. Y., Kwon, O. J., & Koh, W. J. (2010). Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease. Yonsei Medical Journal, 51(6), 888–894.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Lee, H., Park, H. J., Cho, S. N., Bai, G. H., & Kim, S. J. (2000). Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. Journal of Clinical Microbiology, 38(8), 2966–2971.PubMedCentralPubMed Lee, H., Park, H. J., Cho, S. N., Bai, G. H., & Kim, S. J. (2000). Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. Journal of Clinical Microbiology, 38(8), 2966–2971.PubMedCentralPubMed
12.
Zurück zum Zitat Chung, M. J., Lee, K. S., Koh, W. J., Lee, J. H., Kim, T. S., Kwon, O. J., et al. (2005). Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: Comparison between Mycobacterium avium-intracellular complex and Mycobacterium abscessus infection. Journal of Korean Medical Science, 20(5), 777–783.PubMedCentralPubMedCrossRef Chung, M. J., Lee, K. S., Koh, W. J., Lee, J. H., Kim, T. S., Kwon, O. J., et al. (2005). Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: Comparison between Mycobacterium avium-intracellular complex and Mycobacterium abscessus infection. Journal of Korean Medical Science, 20(5), 777–783.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Kitada, S., Kobayashi, K., Ichiyama, S., Takakura, S., Sakatani, M., Suzuki, K., et al. (2008). Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. American Journal of Respiratory and Critical Care Medicine, 177(7), 793–797.PubMedCrossRef Kitada, S., Kobayashi, K., Ichiyama, S., Takakura, S., Sakatani, M., Suzuki, K., et al. (2008). Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. American Journal of Respiratory and Critical Care Medicine, 177(7), 793–797.PubMedCrossRef
14.
15.
Zurück zum Zitat Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef
16.
Zurück zum Zitat EuroQol group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef EuroQol group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
17.
Zurück zum Zitat Rutten-van Molken, M. P., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest, 130(4), 1117–1128.PubMedCrossRef Rutten-van Molken, M. P., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest, 130(4), 1117–1128.PubMedCrossRef
18.
Zurück zum Zitat Lee, Y. K., Nam, H. S., Chuang, L. H., Kim, K. Y., Yang, H. K., Kwon, I. S., et al. (2009). South Korean time trade-off values for EQ-5D health states: Modeling with observed values for 101 health states. Value Health, 12(8), 1187–1193.PubMedCrossRef Lee, Y. K., Nam, H. S., Chuang, L. H., Kim, K. Y., Yang, H. K., Kwon, I. S., et al. (2009). South Korean time trade-off values for EQ-5D health states: Modeling with observed values for 101 health states. Value Health, 12(8), 1187–1193.PubMedCrossRef
19.
Zurück zum Zitat van Manen, J. G., Bindels, P. J., Dekker, F. W., Bottema, B. J., van der Zee, J. S., Ijzermans, C. J., et al. (2003). The influence of COPD on health-related quality of life independent of the influence of comorbidity. Journal of Clinical Epidemiology, 56(12), 1177–1184.PubMedCrossRef van Manen, J. G., Bindels, P. J., Dekker, F. W., Bottema, B. J., van der Zee, J. S., Ijzermans, C. J., et al. (2003). The influence of COPD on health-related quality of life independent of the influence of comorbidity. Journal of Clinical Epidemiology, 56(12), 1177–1184.PubMedCrossRef
20.
Zurück zum Zitat Hayashi, M., Takayanagi, N., Kanauchi, T., Miyahara, Y., Yanagisawa, T., & Sugita, Y. (2012). Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. American Journal of Respiratory and Critical Care Medicine, 185(5), 575–583.PubMedCrossRef Hayashi, M., Takayanagi, N., Kanauchi, T., Miyahara, Y., Yanagisawa, T., & Sugita, Y. (2012). Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. American Journal of Respiratory and Critical Care Medicine, 185(5), 575–583.PubMedCrossRef
21.
Zurück zum Zitat Khan, Z., Miller, A., Bachan, M., & Donath, J. (2010). Mycobacterium avium complex (MAC) lung disease in two inner city community hospitals: Recognition, prevalence, co-infection with Mycobacterium tuberculosis (MTB) and pulmonary function (PF) improvements after treatment. The Open Respiratory Medicine Journal, 4, 76–81.PubMedCentralPubMedCrossRef Khan, Z., Miller, A., Bachan, M., & Donath, J. (2010). Mycobacterium avium complex (MAC) lung disease in two inner city community hospitals: Recognition, prevalence, co-infection with Mycobacterium tuberculosis (MTB) and pulmonary function (PF) improvements after treatment. The Open Respiratory Medicine Journal, 4, 76–81.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Lee, M. R., Yang, C. Y., Chang, K. P., Keng, L. T., Yen, D. H., Wang, J. Y., et al. (2013). Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLoS One, 8(3), e58214.PubMedCentralPubMedCrossRef Lee, M. R., Yang, C. Y., Chang, K. P., Keng, L. T., Yen, D. H., Wang, J. Y., et al. (2013). Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLoS One, 8(3), e58214.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Oh, E. G., Bang, S. Y., Kim, Y. S., Park, M. S., & Kim, S. K. (2009). Health-related quality of life among Koreans with chronic respiratory disease. The International Journal of Tuberculosis and Lung Disease, 13(5), 580–586.PubMed Oh, E. G., Bang, S. Y., Kim, Y. S., Park, M. S., & Kim, S. K. (2009). Health-related quality of life among Koreans with chronic respiratory disease. The International Journal of Tuberculosis and Lung Disease, 13(5), 580–586.PubMed
24.
Zurück zum Zitat Pickard, A. S., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine, 102(4), 519–536.PubMedCrossRef Pickard, A. S., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine, 102(4), 519–536.PubMedCrossRef
25.
Zurück zum Zitat Cook, J. L. (2010). Nontuberculous mycobacteria: Opportunistic environmental pathogens for predisposed hosts. British Medical Bulletin, 96, 45–59.PubMedCrossRef Cook, J. L. (2010). Nontuberculous mycobacteria: Opportunistic environmental pathogens for predisposed hosts. British Medical Bulletin, 96, 45–59.PubMedCrossRef
26.
Zurück zum Zitat Puhan, M. A., Guyatt, G. H., Goldstein, R., Mador, J., McKim, D., Stahl, E., et al. (2007). Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respiratory Medicine, 101(2), 308–316.PubMedCrossRef Puhan, M. A., Guyatt, G. H., Goldstein, R., Mador, J., McKim, D., Stahl, E., et al. (2007). Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respiratory Medicine, 101(2), 308–316.PubMedCrossRef
27.
Zurück zum Zitat Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.PubMedCrossRef Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.PubMedCrossRef
28.
Zurück zum Zitat Harper, R., Brazier, J. E., Waterhouse, J. C., Walters, S. J., Jones, N. M., & Howard, P. (1997). Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax, 52(10), 879–887.PubMedCentralPubMedCrossRef Harper, R., Brazier, J. E., Waterhouse, J. C., Walters, S. J., Jones, N. M., & Howard, P. (1997). Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax, 52(10), 879–887.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Szende, A., Leidy, N. K., Stahl, E., & Svensson, K. (2009). Estimating health utilities in patients with asthma and COPD: Evidence on the performance of EQ-5D and SF-6D. Quality of Life Research, 18(2), 267–272.PubMedCrossRef Szende, A., Leidy, N. K., Stahl, E., & Svensson, K. (2009). Estimating health utilities in patients with asthma and COPD: Evidence on the performance of EQ-5D and SF-6D. Quality of Life Research, 18(2), 267–272.PubMedCrossRef
30.
Zurück zum Zitat Huang, C. T., Tsai, Y. J., Wu, H. D., Wang, J. Y., Yu, C. J., Lee, L. N., et al. (2012). Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. The International Journal of Tuberculosis and Lung Disease, 16(4), 539–545.PubMedCrossRef Huang, C. T., Tsai, Y. J., Wu, H. D., Wang, J. Y., Yu, C. J., Lee, L. N., et al. (2012). Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. The International Journal of Tuberculosis and Lung Disease, 16(4), 539–545.PubMedCrossRef
31.
Zurück zum Zitat Antonelli-Incalzi, R., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., et al. (2003). Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal, 22(3), 444–449.PubMedCrossRef Antonelli-Incalzi, R., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., et al. (2003). Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal, 22(3), 444–449.PubMedCrossRef
Metadaten
Titel
Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease
verfasst von
Ji Young Hong
Sang A. Lee
Song Yee Kim
Kyung Soo Chung
Sung Woo Moon
Eun Young Kim
Ji Ye Jung
Moo Suk Park
Young Sam Kim
Se Kyu Kim
Joon Chang
Young Ae Kang
Publikationsdatum
01.12.2014
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 10/2014
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0727-3

Weitere Artikel der Ausgabe 10/2014

Quality of Life Research 10/2014 Zur Ausgabe